Therapeutic efficacy of nanomedicines for prostate cancer: An update

被引：17
作者：
Lakshmanan, Vinoth-Kumar [1 ]
机构：
[1] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, 160 Baekseo Ro, Gwangju 61469, South Korea
来源：
INVESTIGATIVE AND CLINICAL UROLOGY | 2016年 / 57卷 / 01期
关键词：
Diagnosis; Drug delivery systems; Nanomedicine; Prostate neoplasms; Therapy; DRUG-DELIVERY; TARGETED DELIVERY; IN-VITRO; POLYMERIC NANOPARTICLES; MAGNETIC NANOPARTICLES; GOLD NANOPARTICLES; PLGA NANOPARTICLES; CARBON NANOTUBES; RECEPTOR; DOCETAXEL;
D O I：
10.4111/icu.2016.57.1.21
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recent advances in cancer nanomedicine have attracted remarkable attention in medical sectors. Pharmacologic research on nanomedicines, including targeted cancer therapy, has increased dramatically in the past 5 years. The success stories of nanomedicines in the clinical field include the fabrication of nanomedicines that show maximum loading efficiency into carriers, maximal release kinetics, and minimum toxicity to healthy cells. Nanoparticle-mediated medicines have been developed to specifically target prostate cancer tissue by use of aptamers, antibody targeting, and sustained release of nanomedicines in a dose-and time-dependent manner. Nanomedicines have been developed for therapeutic application in combination with image-guided therapy in real time. The scope of one of these nanomedicines, Abraxane (paclitaxel), may be extended to prostate cancer therapeutic applications for better quality of patient life and longer survival. This review provides an update on the latest directions and developments in nanomedicines for prostate cancer.
引用
收藏
页码：21 / 29
页数：9
相关论文
共 79 条
  • [1] Ahmad Zahoor, 2006, Indian J Chest Dis Allied Sci, V48, P171
  • [2] JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
    Arts, Janine
    King, Peter
    Marien, Ann
    Floren, Wim
    Belien, Ann
    Janssen, Lut
    Pilatte, Isabelle
    Roux, Bruno
    Decrane, Laurence
    Gilissen, Ron
    Hickson, Ian
    Vreys, Veronique
    Cox, Eugene
    Bol, Kees
    Talloen, Willem
    Goris, Ilse
    Andries, Luc
    Du Jardin, Marc
    Janicot, Michel
    Page, Martin
    van Emelen, Kristof
    Angibaud, Patrick
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (22) : 6841 - 6851
  • [3] PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties
    Avgoustakis, K
    Beletsi, A
    Panagi, Z
    Klepetsanis, P
    Karydas, AG
    Ithakissios, DS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) : 123 - 135
  • [4] Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer
    Axiak-Bechtel, Andra M.
    Upendran, Anandhi
    Lattimer, Jimmy C.
    Kelsey, James
    Cutler, Cathy S.
    Selting, Kim A.
    Bryan, Jeffrey N.
    Henry, Carolyn J.
    Boote, Evan
    Tate, Deborah J.
    Bryan, Margaret E.
    Katti, Kattesh V.
    Kannan, Raghuraman
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 5001 - 5011
  • [5] Docetaxel-related side effects and their management
    Baker, Jackie
    Ajani, Jaffer
    Scotte, Florian
    Winther, Dorte
    Martin, Miguel
    Aapro, Matti S.
    von Minckwitz, Gunter
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2009, 13 (01) : 49 - 59
  • [6] Quantum dot-based lab-on-a-bead system for multiplexed detection of free and total prostate-specific antigens in clinical human serum samples
    Brazhnik, Kristina
    Sokolova, Zinaida
    Baryshnikova, Maria
    Bilan, Regina
    Efimov, Anton
    Nabiev, Igor
    Sukhanova, Alyona
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (05) : 1065 - 1075
  • [7] Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol
    Budhian, A
    Siegel, SJ
    Winey, KI
    [J]. JOURNAL OF MICROENCAPSULATION, 2005, 22 (07) : 773 - 785
  • [8] PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
    Calvo, P
    Gouritin, B
    Brigger, I
    Lasmezas, C
    Deslys, JP
    Williams, A
    Andreux, JP
    Dormont, D
    Couvreur, P
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2001, 111 (02) : 151 - 155
  • [9] Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide
    Chen, Baoling
    Pan, Ran
    Askhatova, Diana
    Chen, P.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 3303 - 3314
  • [10] PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy
    Chen, Zhihang
    Penet, Marie-France
    Nimmagadda, Sridhar
    Li, Cong
    Banerjee, Sangeeta R.
    Winnard, Paul T., Jr.
    Artemov, Dmitri
    Glunde, Kristine
    Pomper, Martin G.
    Bhujwalla, Zaver M.
    [J]. ACS NANO, 2012, 6 (09) : 7752 - 7762
12345678